Drug Stocks on Watch as Bipartisian Bill Expected on Capping Price Increases

September 15, 2016 8:31 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Pharmaceutical stocks are on watch Thursday amid reports a bipartisan bill to cap drug price increases will be introduced in both on the House and Senate. The bill is expected to require drug makers to notify the Department of HHS if a price increase of 10% or more is planned.

Related Stocks:

  • Allergan (NYSE: AGN)
  • Mallinckrodt (NYSE: MNK)
  • Mylan (NASDAQ: MYL)
  • Valeant Pharma (NYSE: VRX)
  • Teva (NASDAQ: TEVA)
  • Perrigo (NYSE: PRGO)
  • Shire plc (NASDAQ: SHPG)
  • Endo Int'l (NASDAQ: ENDP)

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Related Entities

Raising Prices

Add Your Comment